Total Funding
42
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Athenex is a biopharmaceutical company that develops and discovers novel therapies for treating cancer and related conditions.
Jeff Yordon: President & COOPast Role: Sagent Pharmaceuticals, Chairman, CEO & Founder
Rudolf Kwan: Chief Medical OfficerPast Role: Chiron Corporation, Held Similar Positions
About the Company
Athenex focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases. Its mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes.
The company was founded in 2003 in Buffalo, New York, and has since grown to have operations across the U.S.,
China, Hong Kong, Taiwan, and the U.K.
